BIOMAT Database Logo BIOMAT Database Logo

Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. 1999

Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Department of Neurology, Baylor College of Medicine, and Baylor-Methodist Multiple Sclerosis Center, Houston 77030, USA. jzang@bcm.tmc.edu

T cell responses to myelin basic protein (MBP) may play an important role in the pathogenesis of multiple sclerosis (MS). If MBP-reactive T cells are involved in the disease processes and undergo clonal activation and expansion, their precursor frequency would be increased in patients with MS. The frequency of MBP-reactive T cells is also influenced by regulatory mechanisms in vivo, including apoptotic deletion. In this study, we examined changes in the frequency of MBP-reactive T cells in patients with MS as a function of the apoptotic deletional mechanism in vivo, using a cell culture-based assay. A significantly increased frequency of MBP-reactive T cells was found in patients with MS relative to healthy individuals only when Fas-ligand antibody was used to block apoptosis. This result indicates that a significant proportion of MBP-reactive T cells are sensitive to apoptosis and are not deleted in vivo in patients with MS, as opposed to healthy individuals, thus suggesting a functional deficit in apoptotic deletional mechanism. Surviving Fas-sensitive MBP-reactive T cell lines represent distinct subpopulations preferentially recognizing the 111-139 region of MBP and exhibiting a Th2 cytokine profile. The findings are relevant to our understanding of regulation of MBP-reactive T cells in vivo in MS.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004676 Myelin Basic Protein An abundant cytosolic protein that plays a critical role in the structure of multilamellar myelin. Myelin basic protein binds to the cytosolic sides of myelin cell membranes and causes a tight adhesion between opposing cell membranes. Golli-MBP1 Protein,Golli-MBP2 Protein,HOG5 Protein,HOG7 Protein,MBP1 Protein,MBP2 Protein,MBP3 Protein,MBP4 Protein,Myelin Basic Protein, 17.2 kDa Isoform,Myelin Basic Protein, 18.5 kDa Isoform,Myelin Basic Protein, 20.2 kDa Isoform,Myelin Basic Protein, 21.5 kDa Isoform,Myelin Basic Protein, Isoform 1,Myelin Basic Protein, Isoform 2,Myelin Basic Protein, Isoform 3,Myelin Basic Protein, Isoform 4,Myelin Basic Protein, Isoform 5,Myelin Basic Protein, Isoform 6,Myelin Basic Protein, Isoform 7,Golli MBP1 Protein,Golli MBP2 Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D053222 Fas Ligand Protein A transmembrane protein belonging to the tumor necrosis factor superfamily that was originally discovered on cells of the lymphoid-myeloid lineage, including activated T-LYMPHOCYTES and NATURAL KILLER CELLS. It plays an important role in immune homeostasis and cell-mediated toxicity by binding to the FAS RECEPTOR and triggering APOPTOSIS. Antigens, CD178,CD178 Antigens,Tumor Necrosis Factor Ligand Superfamily Member 6,CD178 Antigen,CD95 Antigen Ligand,CD95 Ligand,CD95L,Fas Ligand,Fas Ligand (FasL),FasL Protein,TNF Superfamily, Member 6,Antigen, CD178

Related Publications

Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
November 1998, Journal of neuroimmunology,
Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
T cells responsive to myelin basic protein in patients with multiple sclerosis.
February 1990, Science (New York, N.Y.),
Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Myelin basic protein-reactive T cells in multiple sclerosis: pathologic relevance and therapeutic targeting.
January 1994, Cytotechnology,
Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis.
February 1996, Annals of neurology,
Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Cytokine mRNA profile of myelin basic protein reactive T-cell clones in patients with multiple sclerosis.
January 1998, Autoimmunity,
Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Multiple sclerosis: occurrence of myelin basic protein peptide-reactive T cells in healthy family members.
March 1994, Acta neurologica Scandinavica,
Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
July 1997, Annals of neurology,
Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Myelin basic protein-responsive blood T lymphocytes in patients with multiple sclerosis.
January 1985, Journal of neuroscience research,
Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Myelin basic protein-stimulated rosette-forming T cells in multiple sclerosis.
February 1978, Neurochemical research,
Y C Zang, and M M Kozovska, and J Hong, and S Li, and S Mann, and J M Killian, and V M Rivera, and J Z Zhang
Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis.
April 1992, European journal of immunology,
Copied contents to your clipboard!